Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 12 of 12 for “"Anticoagulant Therapy"”.
-
Stroke risk factors, outcomes and models of stroke care in a culturally and linguistically Diverse (CALD) elderly population.
… be suboptimal in elderly patients. For example, anticoagulant therapy for stroke prevention in patients with atrial fibrillation was underused, particularly in NESB patients (Chapter 2). The reasons for under-usage of anticoagulant therapy were investigated in a general practitioner survey …
-
Duration of oral anticoagulation in first-episode idiopathic deep vein thrombosis: A Markov decision analysis.
… assess quality of life for patients on warfarin therapy for DVT and for patients with post-thrombosic syndrome. A third objective was to determine if quality of life for these two health states differed between patients and healthy volunteers. Methods. Decision analysis with a Markov model was …
-
Kapilläre Thromboplastinzeit : Untersuchung zur Validität des INR-Wertes aus Kapillarblut bei Kindern mit und ohne Marcumartherapie mit Hilfe des CoaguChek-Systems
The practical organization of oral anticoagulant therapy with pediatric patients is often difficult. As an encouring alternative portable coagulation time monitors were developed in the last years to measure the prothrombin time with capillary blood. To evaluate the reliability of this method …
-
The effect of distance to health facility on the maintenance of INR therapeutic ranges in rheumatic heart disease patients from Cape Town
… of therapeutic ranges in RHD patients on anticoagulant therapy is correlated with the distance travelled from patient's residence to the clinic where INR monitoring takes place. Part C: presents the entire project in a format suitable for journal submission. The background of this research …
-
ASSOCIATION BETWEEN ATRIAL SIZE AND CEREBROVASCULAR EVENTS: A RETROSPECTIVE, COHORT STUDY
… Patients with a history of AF or receiving anticoagulant therapy were excluded. Only the first TTE of each calendar year was included in the analysis (index echocardiogram). LAE was categorized by LAVi as absent (≤34 mL/m2), mild (>34 and ≤41 mL/m2), moderate (>41 and ≤48 mL/m2), or severe …
-
A novel polymeric prosthetic heart valve: design, manufacture, and testing
… designed with the aim of overcoming the need for anticoagulant therapy, which is required for current mechanical prostheses; while also having lifelong durability, which current bioprosthetic heart valves are not able to achieve. Inspired by the anisotropic architecture of collagen in the natural …
-
Prediction of pulmonary embolism in children
… We additionally required the use of anticoagulant therapy to establish the diagnosis of PE. Results: Among 152 patients who presented to an ED setting, the prevalence of PE was 16.4%. The most frequent presenting symptoms in children with PE were chest pain (76%) and shortness of …
-
The impact of a direct oral anticoagulant in cardiovascular disease
Novel oral anticoagulants (NOACs) have uncomplicated dosing with no need for INR monitoring and fewer possible drug and food interactions compared to warfarin, which may result in improved adherence to treatment and may offset the high retail cost of NOACs. Rivaroxaban 10mg is the only NOAC …
-
Development of coagulation monitoring devices
… and mechanisms of thrombosis. Various classes of anticoagulant drugs and mechanisms by which they exert their activity were explained. A number of substances used to induce clotting and their application in coagulation monitoring assay devices were discussed, as were issues relating to substrate …
-
Characterisation of the cross-linking and calcification associated with glutaraldehyde-treated cardic bioprostheses.
… they do not necessarily require long-term anticoagulant therapy however, dystrophic calcification can lead to early failure. The actual mechanism of calcification is still poorly understood despite several established possible factors associated with it. Amongst these is the glutaraldehyde …
-
RECYCLING OF WASTE BLOOD INTO FUNCTIONAL CARBON NANOPARTICLES
… blood waste management and explores alternative anticoagulant therapies. Through a hydrothermal process, optimal conditions for HD synthesis were identified at 230°C for 10 minutes, maximizing fluorescence intensity and carbon nanoparticle quality. Characterization confirmed HDs’ carbon-based …
-
PATHOPHYSIOLOGY OF VON WILLEBRAND FACTOR IN BLEEDING AND THROMBOSIS
… rare but important side effects of replacement therapy administrated to type 3 VWD patients. In Chapter 6, the prevalence of alloantibodies against VWF in the 3WINTERS-IPS cohort has been assessed. Because of the lack of a gold-standard, we chose to carry out an indirect ELISA assay able to …